Gui de Chauliac Hospital - Montpellier University Hospital
Gui de Chauliac Hospital - Montpellier University Hospital
Montpellier, France2 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| TicAgreLor Versus Placebo to Prevent Cerebral ISCHemia in anEuRysmal Low Grade SAH A Double Blinded Randomised Controlled Study | Embolism and Thrombosis, Hemorrhage, Intracranial Hemorrhages, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Subarachnoid Hemorrhage, Aneurysmal, Thromboembolism, brain disorder, brain ischemia, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, nervous system disorder, subarachnoid hemorrhage, vascular disorder | Not yet recruiting | Phase 3 | 2026-09-15 | NCT07821008 | |
| Comparative Study of Two Vaccination Schedules for the Subunit Herpes Zoster Vaccine in Multiple Sclerosis and Neuromyelitis Optica Spectrum Disease Patients Treated With Anti-CD20 Therapy: an Open-label Randomised Controlled Trial | CNS demyelinating autoimmune disease, DNA Virus Infections, Herpesviridae infectious disease, Infections, Varicella Zoster Virus Infection, autoimmune disease, autoimmune disorder of the nervous system, chickenpox, demyelinating disease, herpes zoster, immune system disorder, multiple sclerosis, nervous system disorder, viral infectious disease | Not yet recruiting | Phase 4 | 2026-09-14 | NCT07818356 |